Stemline Investors Reminder: Hagens Berman Reminds Investors in Stemline Therapeutics of the April 4, 2017 Lead Plaintiff Deadline
March 17, 2017 16:00 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 17, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Stemline Therapeutics, Inc. (NASDAQ:STML) of the April 4, 2017 Lead Plaintiff deadline in the...
Stemline Investor Loss Alert: Hagens Berman Alerts Investors in Stemline Therapeutics to Expanded Class Period and Reminds Them of Lead Plaintiff Deadline
February 15, 2017 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Stemline Therapeutics, Inc. (NASDAQ:STML) to the expanded class period in the pending securities...
Stemline Investor Loss Alert: Hagens Berman Alerts Investors in Stemline Therapeutics to Securities Class Action and Lead Plaintiff Deadline
February 06, 2017 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Stemline Therapeutics, Inc. (NASDAQ:STML) to the April 4, 2017 Lead Plaintiff deadline in the...